Free Trial

Hoth Therapeutics (HOTH) Insider Trading & Ownership

Hoth Therapeutics logo
$0.86
+0.01 (+1.18%)
(As of 11/1/2024 ET)

Hoth Therapeutics (NASDAQ:HOTH) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
10.56%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$16,750.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get HOTH Insider Trade Alerts

Want to know when executives and insiders are buying or selling Hoth Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

HOTH Insider Buying and Selling by Quarter

Hoth Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/16/2024Robb KnieCEOBuy25,000$0.67$16,750.00  
(Data available from 1/1/2013 forward)

HOTH Insider Trading Activity - Frequently Asked Questions

The list of insiders at Hoth Therapeutics includes Robb Knie. Learn more on insiders at HOTH.

10.56% of Hoth Therapeutics stock is owned by insiders. Learn more on HOTH's insider holdings.

The following insider purchased HOTH shares in the last 24 months: Robb Knie ($16,750.00).

Insiders have purchased a total of 25,000 HOTH shares in the last 24 months for a total of $16,750.00 bought.

Hoth Therapeutics Key Executives

  • Mr. Robb Knie (Age 55)
    President, CEO & Chairman
    Compensation: $844.01k
    1 recent trades
  • Mr. David S. Briones (Age 48)
    Chief Financial Officer
  • Ms. Hayley Springer
    Executive Vice President of Operations


This page (NASDAQ:HOTH) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners